How Payment Cuts Undermine Quality Improvement in Cardiology

The American College of Cardiology launched the Campaign for Patient Access to oppose cuts to the United States Medicare physician fee schedule affecting cardiovascular care. Its central warning travels well beyond that campaign: when reimbursement falls while operating costs rise, clinicians have less time, staffing and flexibility to improve care. Patients experience those constraints as delayed appointments, rushed reviews and fragmented treatment.

Cardiology quality improvement relies heavily on work that sits outside a single fee-for-service encounter. Teams review readmissions, maintain registries, reconcile medicines, contact patients after discharge and redesign clinical pathways. Many of these activities are treated as overhead because they do not map neatly to one billable service, even though they prevent deterioration and avoidable hospital admission.

Australia faces the same tension within a mixed system of Medicare Benefits Schedule rebates, state-funded public hospitals and privately insured care. Specialist rebates have at times been frozen or indexed below costs while service demand continues to rise. The policy contradiction is clear: payment restraint can be presented as efficiency, yet underfunding the conditions for improvement can make cardiovascular care less safe, less equitable and ultimately more expensive.

Payment levels become clinical capacity

A consultation fee does more than set a price for a patient visit. It shapes how many nurses, practice managers and data analysts a service can employ, how long a cardiologist can spend with a complex patient and whether post-discharge calls occur. Payment reduction is therefore a change to the production model of care rather than a neutral accounting adjustment.

Most improvement cycles begin with measurement: teams identify variation in emergency readmissions, medication errors or follow-up, test a change and then check whether results last. Registries, audit meetings and patient feedback require protected time between clinics. When margins tighten, that time is usually the easiest resource to absorb informally, leaving improvement dependent on goodwill and burnout.

Repeated reductions can also change what a service is willing to count as its work. Short visits may generate more billable encounters while reducing continuity, and complex patients may be referred elsewhere because follow-up is financially difficult to sustain. A cardiology practice can meet activity targets yet weaken the prevention, coordination and surveillance on which long-term outcomes depend.

The Australian reform context

Australia’s familiar pathway often runs from a GP referral to an MBS-rebated specialist consultation, with public outpatient services and private insurance adding different payment arrangements. Medicare rebates are set through Commonwealth decisions, while private insurers negotiate contracts and state governments fund public hospitals. Successive freezes or restrained indexation of specialist rebates have periodically left fees below the cost of providing high-quality practice.

Local geography changes the consequences. Melbourne and Sydney have dense networks of private hospitals, cardiac imaging and specialist practices, so services may cross-subsidise less-funded work or redirect demand within a large market. Regional New South Wales, northern Queensland and remote communities in the Northern Territory face thin workforces and long travel distances. A lost appointment or withdrawn service can impose much greater costs on patients there.

The same pressure can also flow through public systems. State-funded cardiology units employ clinicians under different arrangements from private specialists, yet they compete for the same nurses, trainees and cardiologists. Cuts to community referrals can push activity back into emergency departments, where care is expensive and continuity is limited. Telehealth helps, but it cannot replace physical diagnostics, procedures and hands-on review.

The operating effects are direct and cumulative:

Feature of care	Stable, indexed specialist funding	Payment cuts or prolonged underpayment
Protected time	Audits, registries and case review are planned	Improvement work is squeezed between billable encounters
Continuity	Teams can follow up early after discharge	Contact time falls and discharge problems may return
Patient selection	Complex and high-risk patients can be supported	Services may avoid costly patients or transfer them
Data quality	Records support credible measurement and safety checks	Administrative pressure can reduce completeness and continuity
Rural access	Incentives can support staffing and telehealth	Thin markets make lost capacity difficult to replace

Consequences for patients and practices

For patients, constrained specialist capacity often appears first as access: longer waits, fewer follow-up opportunities and greater reliance on emergency assessment. Heart failure and atrial fibrillation programmes depend on early adjustment of medicines and close monitoring after admission. If review is rushed, preventable deterioration may return as a readmission, imposing physical, financial and emotional costs on the patient and the health system.

Equity effects are particularly serious where patients already travel. A person from a rural area may defer symptoms to avoid a long journey, then present later with more complex disease. Aboriginal and Torres Strait Islander communities require services that are culturally safe, locally connected and supported by reliable transport and telehealth. A payment model that makes those services harder to sustain can erase gains made through earlier and more coordinated care.

For practices, underpayment can encourage coding focused on volume rather than outcomes, selective acceptance and reduced participation in registries or research. It can also make it harder to absorb the cost of interpreter services, rural outreach and multidisciplinary team care. These responses may produce superficially stable activity data while leaving the underlying burden of illness unmeasured and increasingly concentrated in people with the fewest alternatives.

Reforms that reward measurable quality

Reform should begin with predictable funding that reflects the real cost of specialist work. A transparent indexation mechanism, combined with separately funded quality infrastructure, would protect the registries, clinical audits, pharmacy support and care coordination that produce better outcomes. Payment models can then reward selected measures without pretending that a standard consultation already contains every task required for safe chronic disease management.

Value-based arrangements need careful design. Hospitals serving older, poorer or more clinically complex populations must be assessed with adequate risk adjustment, or incentives will punish commitment to those patients. Shared savings, bundled-care payments or chronic care agreements can support continuity, provided they include rural weighting and do not create incentives to avoid high-cost cases. Commonwealth, state and private contracts should use compatible measures so patients do not fall between funding systems.

Implementation can build on work already familiar across Australia: the Australian Commission on Safety and Quality in Health Care, clinical audits, registries and quality projects led by the Royal Australasian College of Physicians, the Cardiac Society of Australia and New Zealand, and organisations such as the Heart Foundation. Ministers and parliamentary committees can scrutinise the evidence, require transparent modelling and revise legislative or administrative settings where existing authority is insufficient. Consumer and community involvement should shape measures of access, trust and outcomes.

Protect the capacity to improve cardiology care

The Campaign for Patient Access demonstrated that payment policy is also a patient-access issue. Its use of policy analysis, legal updates, practice resources and personal stories offers a practical advocacy model. Australian cardiology services can apply the same discipline by presenting waiting times, travel burdens, staffing gaps, readmissions and the cost of unfunded improvement work in one clear account.

Clinicians and health services can submit evidence to federal and state decision-makers, publish de-identified quality data and explain where payment changes have affected continuity. Patients and families can give informed consent to share experiences of delayed care, travel and out-of-pocket costs. Those stories should accompany, rather than replace, audited data, and should be directed to ministers, parliamentary committees, insurers and the professional bodies that influence cardiology policy.

Federal and state governments, insurers, health services and medical colleges should make stable, equitable cardiology funding a shared priority. Before implementing a reduction, they should model its effect on waiting times, rural coverage, emergency demand and the capacity to improve care, then publish the findings. Make that transparency non-negotiable, protect dedicated quality-improvement time, and ensure payment decisions strengthen safer care rather than quietly transfer its costs to patients.